Singapore markets closed

Inovio Pharmaceuticals, Inc. (INO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
6.74-0.30 (-4.26%)
At close: 4:00PM EDT
6.76 +0.02 (+0.30%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 51.48B
Enterprise value 31.07B
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/sales (ttm)204.30
Price/book (mrq)2.90
Enterprise value/revenue 3165.13
Enterprise value/EBITDA 7-8.26

Trading information

Stock price history

Beta (5Y monthly) 0.70
52-week change 3-35.50%
S&P500 52-week change 333.64%
52-week high 319.00
52-week low 35.81
50-day moving average 37.38
200-day moving average 38.01

Share statistics

Avg vol (3-month) 34.11M
Avg vol (10-day) 32.44M
Shares outstanding 5210.36M
Implied shares outstanding 6N/A
Float 8206.97M
% held by insiders 11.66%
% held by institutions 135.96%
Shares short (29 Sep 2021) 445.21M
Short ratio (29 Sep 2021) 412.06
Short % of float (29 Sep 2021) 421.85%
Short % of shares outstanding (29 Sep 2021) 421.49%
Shares short (prior month 30 Aug 2021) 443.54M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:4
Last split date 305 Jun 2014

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Jun 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)-3,117.70%

Management effectiveness

Return on assets (ttm)-24.33%
Return on equity (ttm)-40.78%

Income statement

Revenue (ttm)6.46M
Revenue per share (ttm)0.03
Quarterly revenue growth (yoy)2.10%
Gross profit (ttm)-86.83M
EBITDA -198.09M
Net income avi to common (ttm)-141.71M
Diluted EPS (ttm)-0.75
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)443.68M
Total cash per share (mrq)2.11
Total debt (mrq)33.8M
Total debt/equity (mrq)6.65
Current ratio (mrq)10.48
Book value per share (mrq)2.42

Cash flow statement

Operating cash flow (ttm)-256.7M
Levered free cash flow (ttm)-177.41M